Very early researchStudy completedNCT04103333What this trial is testingAngelman Syndrome (AS) Biomarker StudyWho this might be right forAngelman SyndromeChromosome 15q Duplication (dup15q) Syndrome Biogen 20
Not applicableLooking for participantsNCT06353620What this trial is testingStructural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With EpilepsyWho this might be right forEpilepsyAngelman SyndromeDup15q Syndrome IRCCS Eugenio Medea 120
Testing effectiveness (Phase 2)Study completedNCT03694275What this trial is testingA Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)Who this might be right for15q Duplication SyndromeCDKL5 Deficiency Disease Takeda 20
Very early researchUnknownNCT05281965What this trial is testingA Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication SyndromeWho this might be right forAutismTreatment AdherenceRetinoic Acid+1 more Second Affiliated Hospital, School of Medicine, Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT05307679What this trial is testingEvaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q SyndromeWho this might be right forDup15q Syndrome Hoffmann-La Roche 7
Not applicableEnrolling By InvitationNCT03836300What this trial is testingParent and Infant Inter(X)Action Intervention (PIXI)Who this might be right forFragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more RTI International 120
Testing effectiveness (Phase 2)Study completedNCT03650452What this trial is testingA Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesWho this might be right forEpilepsyDravet SyndromeLennox-Gastaut Syndrome Takeda 141
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07079696What this trial is testingInvestigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication SyndromeWho this might be right forDup15q SyndromeAutism Spectrum DisorderTherapy+1 more Second Affiliated Hospital, School of Medicine, Zhejiang University 90